If you need more lookups,
subscriptions start at $34 USD/month.
Divor Kiseljak Location
Lausanne, VD, CH
Divor Kiseljak Work
Chief Science and Technology Officer @ (May 2026 - Present)
Chief Operating Officer @ (April 2022 - May 2026)
Senior Director Of Operations and Process Science @ (December 2019 - April 2022)
Director of Process Science @ (February 2019 - December 2019)
Senior Principal Scientist @ (February 2015 - February 2019)
Principal Scientist @ (October 2012 - February 2015)
Divor Kiseljak Education
EPFL
Doctor of Philosophy - PhD (Biotechnology and Bioengineering)
2008-2012
University of Zagreb / Sveučilište u Zagrebu
Master's degree (Molecular Biology)
2001-2007
Divor Kiseljak Skills
Analytical Method Validation
Biologics
Biopharmaceuticals
Biosimilars
Biotechnology
Business Development
Business Strategy
C Level Management
C Suite
CMC Regulatory Affairs
CMC development
Cell Biology
Cell Culture
Common Technical Document (CTD)
Cross-functional Team Leadership
Design for Manufacturing
Development strategy
Downstream Processing
Drug Development
Life Sciences
Mammalian Cell Culture
Managment
Molecular Biology
Pricing Strategy
Process Optimization
Product Development
Project Management
Protein Expression
Research and Development (R&D)
Strategic Planning
Strategy Execution
Sustainable Development
Team Building
Team Leadership
Team Management
Technology Governance
Technology Leadership
Technology Management
Technology Transfer
Upstream Processing
Vaccines
Divor Kiseljak Summary
Divor Kiseljak, based in Lausanne, VD, CH, is currently a Chief Science and Technology Officer at ExcellGene SA. Divor Kiseljak brings experience from previous roles at ExcellGene SA. Divor Kiseljak holds a 2008 - 2012 Doctor of Philosophy - PhD in Biotechnology and Bioengineering @ EPFL. With a robust skill set that includes Analytical Method Validation, Biologics, Biopharmaceuticals, Biosimilars, Biotechnology and more. Divor Kiseljak has 1 emails on RocketReach.
Looking for a different Divor Kiseljak?
Find contact details for 700 million professionals.